Bladder Carcinoma Terminated Phase 0 Trials for Lapatinib (DB01259)

Also known as: Urinary bladder carcinoma / Carcinoma urinary bladder / Carcinoma of bladder / Bladder carcinoma NOS / Carcinoma bladder / Bladder neoplasms malignant / Malignant neoplasm of bladder / Bladder cancer / Urinary Bladder Cancer / Malignant neoplasm of bladder, part unspecified / Bladder cancer NOS / Ca bladder

IndicationStatusPhase
DBCOND0036971 (Bladder Carcinoma)Terminated0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01245660A Phase 0 of Neoadjuvant Lapatinib in Infiltrative Bladder Carcinoma Before Cystectomy